Autopsy report · NCT00327197
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
Cause of deathSlow enrollment
“The study was truncated due to the long period of enrollment and the collection of a sufficient amount of data that allowed the scientific objectives to be met”
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 5 years 10 months before it stopped.
- 47 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Industry
- Conditions
- Asthma
- Interventions
- Prednisolone; Bronchoscopy
- Participants
- 47
- Sites
- 1
- Countries
- United Kingdom
Trials that died the same way
- Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
“The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned” - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
“The study was discontinued early due to lack of funding and slow enrollment” - Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
“The study was halted because enrollment was too slow” - Salvage Cryotherapy in Recurrent Prostate Cancer
“Study was ended due to low enrollment” - Study of Vascular Function Before vs After Smoking an E-cigarette as Compared to a Normal Cigarette
“due to recruitment reasons the study was prematurely ended”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.